Fady Tanios, PhD is Vice President, Medical Affairs at Regeneron, leading the General Medicine franchise across cardiovascular disease, metabolism, obesity, and rare diseases. With more than 22 years of experience in the pharmaceutical industry, Fady has held leadership roles in global medical affairs at Regeneron, Boehringer Ingelheim, and Pfizer, driving medical strategy, evidence generation, and product launches. Fady earned a PhD from McGill University and completed postdoctoral research at the Harvard School of Public Health with a focus on lipoprotein kinetics. Fady has co-authored numerous peer-reviewed publications.